| Autor: |
Binkley, M. S., Flerlage, J. E, Borchmann, P., Fuchs, M., Hartmann, S., Eich, H. T., Savage, K. J., Lo, A., Skinnider, B., Akhtar, S., Rauf, M. S., Maghfoor, I., Pinnix, C. C., Steiner, R., Milgrom, S. A., Vega, F., Alomari, M., Zhang, X., Collins, G., Advani, R. H. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p100-101, 2p |
| Abstrakt: |
We measured progression-free survival (PFS), overall survival (OS), transformation rate, and lymphoma-specific death rate. B Introduction: b Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare entity. PFS, OS, transformation, and lymphoma-specific death rates at 10 years were 71.1%, 91.7%, 4.9%, and 3.2% respectively. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text